Novo Nordisk A/s (NVO): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
23 concentrated managers hold it (+2 vs last quarter) with a median weight of 1.0%.
Who owns Novo Nordisk A/s?
Novo Nordisk A/s trades in the U.S. through ADRs, certificates that represent shares of a non-U.S. company. Form 13F counts ADRs while the company reports ordinary shares, so we do not compute percentages. As of Jun 30, 2026, the largest ADR holders reported on Form 13F were Dodge & Cox (20.4 million ADRs), Loomis Sayles (18.6 million ADRs) and Franklin Resources (13.0 million ADRs).
Which institutions hold the most Novo Nordisk A/s shares?
Per Form 13F filings as of Jun 30, 2026, in ADRs:
- 1. Dodge & Cox: 20.4 million ADRs
- 2. Loomis Sayles: 18.6 million ADRs
- 3. Franklin Resources: 13.0 million ADRs
- 4. Price T Rowe Associates: 11.7 million ADRs
- 5. Morgan Stanley: 11.7 million ADRs
- 6. Bank of America: 11.2 million ADRs
- 7. Capital International Investors: 9.7 million ADRs
- 8. Folketrygdfondet: 9.5 million ADRs
- 9. Goldman Sachs Group: 9.2 million ADRs
- 10. Fisher Asset Management: 8.3 million ADRs
Sources:All of the company's proxy statements on EDGAR ↗
We hold 13D and 13G filings made since December 2024: a holder above 5% that has not filed since then does not appear here.
Well-known investors holding it
Quarter flow (concentrated managers)
Change in managers (21 → 23): 3 opened · 1 exited = +2
Net flow in the quarter: +$33.1M (+690 K shares) · bought $65.9M and sold $32.8MShares concentrated managers added minus those they cut, valued at the 13F quarter-end implied price, not each trade's price. It is a different measure from the change in managers: the two can have opposite signs.
The set of concentrated managers changed between quarters: with the set as it was then, 18 held it last quarter (the chart point); with today's set, 21 (the base for the change).
Concentrated managers holding it
- Saratoga Research & Investment ManagementReduced$155M8.5%−0.5 pp
- XxecIncreased$37.3M4.8%+1.7 pp
- Integral Health Asset ManagementNew$28.8M1.2%+1.2 pp
- Academy Capital ManagementReduced$23.0M3.0%−1.5 pp
- JIA Investment Alliance Pte$20.5M1.9%
- Euro Pacific Asset ManagementIncreased$18.2M2.1%+0.4 pp
- Generate Investment ManagementNew$16.8M0.7%+0.7 pp
- Foundation Resource ManagementIncreased$8.5M1.0%+0.0 pp
- Eldred Rock Partners$7.8M1.7%
- AltrafinReduced$6.7M2.6%−0.6 pp
- Lynch Asset Management$5.2M1.4%
- Eastover Investment AdvisorsIncreased$4.1M1.6%+0.1 pp
- Borer Denton & AssociatesReduced$3.4M1.1%−0.0 pp
- Gunderson Capital ManagementReduced$3.3M0.9%−0.0 pp
- Norman Fields, Gottscho Capital Management$2.0M0.6%
Up to 15, sorted by position value. The percentage is the weight in each manager's portfolio.
Other relevant holders
Filers with $100M or more in the stock that do not count as concentrated managers because of their type: they are left out of the counts, the consensus and the accumulation.
- FolketrygdfondetPension or sovereign fund$457M9.8%
Largest holders of NVO (all 13F filers)
- Dodge & Cox20.4 MInvestment firm+1.1 M
- Loomis Sayles18.6 MInvestment firm+1.6 M
- Franklin Resources13.0 MInvestment firm−3.0 M
- Price T Rowe Associates11.7 MInvestment firm+644 K
- Morgan Stanley11.7 MBank or trading desk+791 K
- Bank of America11.2 MBank or trading desk+407 K
- Capital International Investors9.7 MInvestment firm−2.1 M
- Folketrygdfondet9.5 MPension or sovereign fund+442 K
- Goldman Sachs Group9.2 MBank or trading desk+4.1 M
- Fisher Asset Management8.3 MInvestment firm−696 K
- Shares
- 20.4 M
- Change
- +1.1 M
See more
- Type
- Investment firm
- Value
- $978M
- Shares
- 18.6 M
- Change
- +1.6 M
See more
- Type
- Investment firm
- Value
- $891M
- Shares
- 13.0 M
- Change
- −3.0 M
See more
- Type
- Investment firm
- Value
- $625M
- Shares
- 11.7 M
- Change
- +644 K
See more
- Type
- Investment firm
- Value
- $561M
- Shares
- 11.7 M
- Change
- +791 K
See more
- Type
- Bank or trading desk
- Value
- $559M
- Shares
- 11.2 M
- Change
- +407 K
See more
- Type
- Bank or trading desk
- Value
- $536M
- Shares
- 9.7 M
- Change
- −2.1 M
See more
- Type
- Investment firm
- Value
- $468M
- Shares
- 9.5 M
- Change
- +442 K
See more
- Type
- Pension or sovereign fund
- Value
- $457M
- Shares
- 9.2 M
- Change
- +4.1 M
See more
- Type
- Bank or trading desk
- Value
- $440M
- Shares
- 8.3 M
- Change
- −696 K
See more
- Type
- Investment firm
- Value
- $399M
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
This list may be incomplete: we hold 13D and 13G filings made since December 2024. A holder above 5% that has not filed anything since then is not shown here.
No recent filings.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗
Other Health Care stocks in managers' portfolios
Same sector and a similar number of concentrated managers holding them. It is a list to keep exploring, not a recommendation.
- Dianthus TherapeuticsDNTH · 21 managers
- Boston ScientificBSX · 26 managers
- Disc MedicineIRON · 19 managers
- AbivaxABVX · 28 managers
- Becton, DickinsonBDX · 28 managers
- CVS HealthCVS · 18 managers